This inventor holds 3 USPTO granted patents. Top assignee: University of Utah Research Foundation. Active years: 2001-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2004
Title: Allen W Howard, Jr: Innovator in Bioconjugates and Bioactive Agent Delivery
Introduction
Allen W Howard, Jr. is a notable inventor based in Dexter, MI (US). He has made significant contributions to the field of bioconjugates and the targeted delivery of bioactive agents. With a total of 3 patents, his work focuses on innovative solutions for site-specific release in biological systems.
Latest Patents
One of Howard's latest patents involves bioconjugates that comprise a bioactive agent and an organocobalt complex. This invention aims to enhance the delivery of bioactive agents, which are covalently bonded to the cobalt atom of the organocobalt complex. The release of the bioactive agent occurs through the cleavage of the covalent bond, which can be triggered by cellular nucleophiles, enzymatic action, or an external signal such as light or ultrasound. Notably, if photolysis occurs in the presence of a magnetic field, the release of the bioactive agent into surrounding healthy tissue is minimized, showcasing the precision of this innovative approach.
Career Highlights
Howard is affiliated with the University of Utah Research Foundation, where he continues to advance his research in bioconjugates. His work has implications for targeted therapies and drug delivery systems, making significant strides in the medical and pharmaceutical fields.
Collaborations
Throughout his career, Howard has collaborated with esteemed colleagues, including Charles B Grissom and Frederick G West. These partnerships have contributed to the development and refinement of his innovative technologies.
Conclusion
Allen W Howard, Jr. stands out as a pioneering inventor in the realm of bioconjugates and bioactive agent delivery. His contributions are shaping the future of targeted therapies and enhancing the efficacy of medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
